US › Healthcare

Sight Sciences Inc (SGHT)

US · Healthcare · Medical Devices

$8.08-0.74%

Last close · 2026-09-17

Latest quarter · ended 2026-06-30

Revenue

$23.4M

Revenue YoY

+19.5%

Net profit

$-4.4M

EPS

$-0.08

EPS estimate

$-0.15

Net margin

-19.0%

EPS came in at -0.08 against a street estimate of -0.15 — a beat of 46.7%.

Key statistics

Market cap

$448.4M

Forward P/E

0.0

P/B

8.45

Book value

$0.97

EPS (TTM)

$-0.55

52-week high

$9.24

52-week low

$3.19

50-day MA

$6.86

200-day MA

$5.87

Beta

2.50

Analyst view

Analysts rate Sight Sciences Inc a buy (2 buy, 6 hold, 0 sell out of 8) with an average price target of $9.00.

Shareholding

Insiders

20.06%

Institutions

52.39%

Largest institutional holders

Fund	Stake
Long Focus Capital Management, LLC	6.98%
BlackRock Inc	5.14%
Pathstone Holdings LLC	4.35%
Americana Partners, LLC	3.05%
Vanguard Capital Management, LLC	2.64%
B Group, Inc	1.76%
Geode Capital Management, LLC	1.66%
State Street Corp	1.52%

See the full picture

Technicals, trade setups with a published hit rate, AI analysis and earnings-call summaries for Sight Sciences Inc — free to start.

Google Play App Store

Other Healthcare companies

Eli Lilly and Company Johnson & Johnson AbbVie Inc Merck & Company Inc UnitedHealth Group Incorporated Novartis AG ADR AstraZeneca PLC Thermo Fisher Scientific Inc Amgen Inc Novo Nordisk A/S Gilead Sciences Inc Abbott Laboratories

Data updated 2026-09-18.